Bleakley Financial Group LLC Sells 4,415 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Bleakley Financial Group LLC decreased its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 26.5% during the fourth quarter, Holdings Channel reports. The firm owned 12,233 shares of the company’s stock after selling 4,415 shares during the quarter. Bleakley Financial Group LLC’s holdings in Definitive Healthcare were worth $50,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Massachusetts Financial Services Co. MA raised its holdings in Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after acquiring an additional 1,626,813 shares during the period. State Street Corp lifted its stake in shares of Definitive Healthcare by 29.4% in the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after purchasing an additional 317,952 shares during the last quarter. 272 Capital LP increased its position in Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock valued at $4,980,000 after acquiring an additional 476,766 shares during the last quarter. Victory Capital Management Inc. lifted its stake in Definitive Healthcare by 6.5% in the third quarter. Victory Capital Management Inc. now owns 542,170 shares of the company’s stock worth $2,424,000 after purchasing an additional 33,161 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Definitive Healthcare by 5.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 436,132 shares of the company’s stock worth $1,950,000 after purchasing an additional 23,706 shares during the period. 98.67% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 14.84% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on DH shares. Stephens began coverage on Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 target price for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Finally, Barclays restated an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a research note on Monday, January 13th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $5.72.

Definitive Healthcare Stock Performance

DH opened at $5.24 on Thursday. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm has a 50 day moving average of $4.50 and a two-hundred day moving average of $4.40. Definitive Healthcare Corp. has a 12-month low of $3.19 and a 12-month high of $10.62. The firm has a market capitalization of $605.32 million, a PE ratio of -1.69, a P/E/G ratio of 3.94 and a beta of 1.45.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.